
Company Number
03337831
Next Accounts
Sep 2025
Shareholders
ipsen developments ltd
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
Registered Address
5th floor the point, 37 north wharf road, london, W2 1AF
Website
http://ipsen.comPomanda estimates the enterprise value of STERIX LIMITED at £0 based on a Turnover of £0 and 1.2x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of STERIX LIMITED at £0 based on an EBITDA of £-7k and a 5.68x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of STERIX LIMITED at £0 based on Net Assets of £-7.2m and 1.93x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sterix Limited is a live company located in london, W2 1AF with a Companies House number of 03337831. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in March 1997, it's largest shareholder is ipsen developments ltd with a 100% stake. Sterix Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
There is insufficient data available to calculate a health check for Sterix Limited. Company Health Check FAQs
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Sterix Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Sterix Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Sterix Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Sterix Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (46)
- Sterix Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Sterix Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Sterix Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Sterix Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Sterix Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Sterix Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Sterix Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2839.9%, this is a higher level of debt than the average (44.4%)
- - Sterix Limited
- - Industry AVG
Sterix Limited's latest turnover from December 2023 is 0 and the company has net assets of -£7.2 million. According to their latest financial statements, we estimate that Sterix Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | -7,000 | -4,000 | -3,000 | -4,000 | -4,000 | -4,000 | 12,000 | -11,000 | 1,000 | -248,000 | -344,000 | -340,000 | -11,516,000 | -7,983,000 | -10,506,000 |
Interest Payable | 411,000 | 177,000 | 80,000 | 80,000 | 127,000 | 109,000 | 91,000 | 110,000 | 110,000 | 100,000 | 109,000 | 114,000 | 68,000 | 23,000 | 47,000 |
Interest Receivable | 2,000 | ||||||||||||||
Pre-Tax Profit | -418,000 | -181,000 | -83,000 | -84,000 | -131,000 | -113,000 | -79,000 | -121,000 | -109,000 | -348,000 | -453,000 | -452,000 | -11,584,000 | -8,006,000 | -10,553,000 |
Tax | 418,000 | 181,000 | 83,000 | 84,000 | 131,000 | 113,000 | 79,000 | 121,000 | 109,000 | 348,000 | 453,000 | 452,000 | 11,584,000 | 3,573,000 | 10,553,000 |
Profit After Tax | -4,433,000 | ||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | -4,433,000 | ||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | |||||||||||||||
EBITDA* | -7,000 | -4,000 | -3,000 | -4,000 | -4,000 | -4,000 | 12,000 | -11,000 | 1,000 | -248,000 | -344,000 | -340,000 | -11,516,000 | -7,983,000 | -10,506,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 71,000 | 102,000 | 147,000 | 161,000 | 216,000 | ||||||||||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 71,000 | 102,000 | 147,000 | 161,000 | 216,000 | ||||||||||
Stock & work in progress | |||||||||||||||
Trade Debtors | 152,000 | 3,645,000 | 1,414,000 | ||||||||||||
Group Debtors | 254,000 | 249,000 | 130,000 | 108,000 | 128,000 | 118,000 | 121,000 | 98,000 | 164,000 | 124,000 | 359,000 | 3,277,000 | |||
Misc Debtors | 7,000 | 9,000 | 11,000 | 12,000 | 19,000 | 26,000 | 28,000 | 38,000 | 50,000 | 5,000 | 18,000 | 24,000 | 35,000 | ||
Cash | 400,000 | 5,000 | 59,000 | 234,000 | 98,000 | 112,000 | 135,000 | ||||||||
misc current assets | |||||||||||||||
total current assets | 261,000 | 258,000 | 141,000 | 120,000 | 152,000 | 147,000 | 144,000 | 149,000 | 536,000 | 219,000 | 183,000 | 598,000 | 3,393,000 | 3,781,000 | 1,584,000 |
total assets | 261,000 | 258,000 | 141,000 | 120,000 | 152,000 | 147,000 | 144,000 | 149,000 | 536,000 | 219,000 | 254,000 | 700,000 | 3,540,000 | 3,942,000 | 1,800,000 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 7,000 | 6,000 | 7,000 | 6,000 | 6,000 | 5,000 | 5,000 | 6,000 | 7,000 | 30,000 | 70,000 | 269,000 | 3,957,000 | ||
Group/Directors Accounts | 140,000 | 138,000 | 20,000 | 32,000 | 28,000 | 25,000 | 29,000 | 30,000 | 30,000 | ||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 112,000 | 111,000 | 4,524,000 | 11,093,000 | 561,000 | ||||||||||
total current liabilities | 147,000 | 144,000 | 27,000 | 6,000 | 38,000 | 33,000 | 30,000 | 35,000 | 37,000 | 60,000 | 182,000 | 380,000 | 4,524,000 | 11,093,000 | 4,518,000 |
loans | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,650,000 | 7,310,000 | 7,223,000 | 7,471,000 | 6,167,000 | ||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,265,000 | 7,650,000 | 7,310,000 | 7,223,000 | 7,471,000 | 6,167,000 | ||
total liabilities | 7,412,000 | 7,409,000 | 7,292,000 | 7,271,000 | 7,303,000 | 7,298,000 | 7,295,000 | 7,300,000 | 7,687,000 | 7,370,000 | 7,405,000 | 7,851,000 | 10,691,000 | 11,093,000 | 4,518,000 |
net assets | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -2,718,000 |
total shareholders funds | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -7,151,000 | -2,718,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -7,000 | -4,000 | -3,000 | -4,000 | -4,000 | -4,000 | 12,000 | -11,000 | 1,000 | -248,000 | -344,000 | -340,000 | -11,516,000 | -7,983,000 | -10,506,000 |
Depreciation | |||||||||||||||
Amortisation | |||||||||||||||
Tax | 418,000 | 181,000 | 83,000 | 84,000 | 131,000 | 113,000 | 79,000 | 121,000 | 109,000 | 348,000 | 453,000 | 452,000 | 11,584,000 | 3,573,000 | 10,553,000 |
Stock | |||||||||||||||
Debtors | 3,000 | 117,000 | 21,000 | -32,000 | 5,000 | 3,000 | -5,000 | 13,000 | -78,000 | 90,000 | -240,000 | -2,931,000 | -374,000 | 2,220,000 | 1,449,000 |
Creditors | 1,000 | -1,000 | 1,000 | 1,000 | -1,000 | -1,000 | -23,000 | -40,000 | -199,000 | 269,000 | -3,957,000 | 3,957,000 | |||
Accruals and Deferred Income | -112,000 | 1,000 | -4,413,000 | -6,569,000 | 10,532,000 | 561,000 | |||||||||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | 409,000 | 59,000 | 60,000 | 112,000 | 123,000 | 106,000 | 95,000 | 96,000 | 165,000 | -142,000 | 151,000 | -1,101,000 | -6,127,000 | -55,000 | 3,116,000 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | 2,000 | 118,000 | 20,000 | -32,000 | 4,000 | 3,000 | -4,000 | -1,000 | 30,000 | ||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -385,000 | 340,000 | 87,000 | -248,000 | 1,304,000 | 6,167,000 | |||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | -411,000 | -177,000 | -80,000 | -80,000 | -127,000 | -109,000 | -91,000 | -110,000 | -110,000 | -100,000 | -109,000 | -112,000 | -68,000 | -23,000 | -47,000 |
cash flow from financing | -409,000 | -59,000 | -60,000 | -112,000 | -123,000 | -106,000 | -95,000 | -496,000 | 230,000 | 17,000 | -357,000 | 1,192,000 | 6,099,000 | -23,000 | -2,765,000 |
cash and cash equivalents | |||||||||||||||
cash | -400,000 | 395,000 | -54,000 | -175,000 | 136,000 | -14,000 | -23,000 | 135,000 | |||||||
overdraft | |||||||||||||||
change in cash | -400,000 | 395,000 | -54,000 | -175,000 | 136,000 | -14,000 | -23,000 | 135,000 |
Perform a competitor analysis for sterix limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in W 2 area or any other competitors across 12 key performance metrics.
STERIX LIMITED group structure
Sterix Limited has no subsidiary companies.
Ultimate parent company
IPSEN SA
#0018787
2 parents
STERIX LIMITED
03337831
Sterix Limited currently has 2 directors. The longest serving directors include Mr Alexandre Visciglio (May 2021) and Lynne Millar-Kelly (Apr 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Alexandre Visciglio | United Kingdom | 46 years | May 2021 | - | Director |
Lynne Millar-Kelly | United Kingdom | 41 years | Apr 2022 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
-7k
+75%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-7.2m
0%
total assets
261k
+0.01%
cash
0
0%
net assets
Total assets minus all liabilities
company number
03337831
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
March 1997
age
28
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
burginhall 960 limited (May 1997)
accountant
-
auditor
CONSTANTIN
address
5th floor the point, 37 north wharf road, london, W2 1AF
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to sterix limited. Currently there are 0 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for STERIX LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|